Literature DB >> 29786498

HCoV-229E spike protein fusion activation by trypsin-like serine proteases is mediated by proteolytic processing in the S2' region.

Ariane Bonnin1, Adeline Danneels1, Jean Dubuisson1, Anne Goffard1, Sandrine Belouzard1.   

Abstract

Human coronavirus 229E (HCoV-229E) is responsible for common colds. Like other coronaviruses, HCoV-229E exploits cellular proteases to activate fusion mediated by the spike protein. We analysed the proteolytic processing of the HCoV-229E spike protein by trypsin-like serine proteases leading to activation of the fusion process. Unlike in other coronaviruses, HCoV-229E fusion activation appears to be a one-step process. Indeed, cleavage of the S1/S2 interface does not seem to be a prerequisite, and the fusion activation is highly reliant on the S2' region, with arginine residue 683 acting as the recognition site.

Entities:  

Keywords:  HCoV-229E; entry; fusion; spike protein

Mesh:

Substances:

Year:  2018        PMID: 29786498     DOI: 10.1099/jgv.0.001074

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.

Authors:  Jean K Millet; Tiffany Tang; Lakshmi Nathan; Javier A Jaimes; Hung-Lun Hsu; Susan Daniel; Gary R Whittaker
Journal:  J Vis Exp       Date:  2019-03-01       Impact factor: 1.355

2.  SARS-CoV-2 Infection of Ocular Cells from Human Adult Donor Eyes and hESC-Derived Eye Organoids.

Authors:  Bar Makovoz; Rasmus Moeller; Anne Zebitz Eriksen; Benjamin R tenOever; Timothy A Blenkinsop
Journal:  SSRN       Date:  2020-07-15

3.  The S2 Subunit of Infectious Bronchitis Virus Beaudette Is a Determinant of Cellular Tropism.

Authors:  Erica Bickerton; Helena J Maier; Phoebe Stevenson-Leggett; Maria Armesto; Paul Britton
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

4.  Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes.

Authors:  Xiyong Song; Yuejun Shi; Wei Ding; Tongxin Niu; Limeng Sun; Yubei Tan; Yong Chen; Jiale Shi; Qiqi Xiong; Xiaojun Huang; Shaobo Xiao; Yanping Zhu; Chongyun Cheng; Zhen F Fu; Zhi-Jie Liu; Guiqing Peng
Journal:  Nat Commun       Date:  2021-01-08       Impact factor: 14.919

5.  Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein.

Authors:  B Robson
Journal:  Comput Biol Med       Date:  2020-11-21       Impact factor: 4.589

Review 6.  Natural and Nature-Derived Products Targeting Human Coronaviruses.

Authors:  Konstantina Vougogiannopoulou; Angela Corona; Enzo Tramontano; Michael N Alexis; Alexios-Leandros Skaltsounis
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

Review 7.  Coronavirus entry: how we arrived at SARS-CoV-2.

Authors:  Gary R Whittaker; Susan Daniel; Jean K Millet
Journal:  Curr Opin Virol       Date:  2021-03-09       Impact factor: 7.121

8.  The trypsin-enhanced infection of porcine epidemic diarrhea virus is determined by the S2 subunit of the spike glycoprotein.

Authors:  Yubei Tan; Limeng Sun; Gang Wang; Yuejun Shi; Wanyu Dong; Yanan Fu; Zhen Fu; Huanchun Chen; Guiqing Peng
Journal:  J Virol       Date:  2021-03-10       Impact factor: 5.103

9.  Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.

Authors:  Ágústa Gudmundsdottir; Reynir Scheving; Fredrik Lindberg; Bjarki Stefansson
Journal:  J Med Virol       Date:  2020-10-14       Impact factor: 20.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.